1. RPTOR methylation in the peripheral blood and breast cancer in the Chinese population
- Author
-
Qiming Yin, Yifei Yin, Lixi Li, Wenjie Zhou, Xiaoqin Yang, Hong Li, Zhengdong Zhang, Fei Ma, Tian Xu, Shuifang Lei, Wanjian Gu, and Rongxi Yang
- Subjects
Oncology ,medicine.medical_specialty ,education.field_of_study ,RPTOR ,Population ,Case-control study ,Methylation ,Biology ,medicine.disease ,Biochemistry ,Breast cancer ,CpG site ,Internal medicine ,DNA methylation ,Genetics ,medicine ,Risk factor ,education ,Molecular Biology - Abstract
Altered regulatory-associated protein of mTOR, complex 1 (RPTOR) methylation levels in peripheral blood was originally discovered as breast cancer (BC)-associated risk factor in Caucasians. To explore the relationship between RPTOR methylation and BC in the Chinese population, we conducted two independent case–control studies. Peripheral blood samples were collected from a total of 333 sporadic BC cases and 378 healthy female controls for the DNA extraction and bisulfite-specific PCR amplification. Mass spectrometry was applied to quantitatively measure the levels of methylation. The logistic regression, Spearman’s rank correlation, and Non-parametric tests were used for the statistical analyses. In our study, we found an association between BC and RPTOR_CpG_4 hypomethylation in the general population (per-10% of methylation, OR 1.29, P = 0.012), and a weak association between BC and RPTOR_CpG_8 hypomethylation in the women with older age (per-10% of methylation, OR 2.34, P = 0.006). We also identified age as a confounder for the change of RPTOR methylation patterns, especially at RPTOR_CpG_4, which represented differential methylation comparing age groups especially in the BC cases (age
- Published
- 2021
- Full Text
- View/download PDF